chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call representative and described the occurrence of joint pain in an adult female patient who received RABAVERT. On an unknown date, the patient received RABAVERT at an unknown dose. On an unknown date, an unknown time after receiving RABAVERT, the patient experienced joint pain, inflammation localized, burning foot and joint range of motion decreased. On an unknown date, the outcome of the joint pain, inflammation localized, burning foot and joint range of motion decreased were unknown. It was unknown if the reporter considered the joint pain, inflammation localized, burning foot and joint range of motion decreased to be related to RABAVERT. Additional details were provided as follows: The patient complained of severe joint pain in all extremities (left knee) and was not able to stretch leg. The patient also reported that her foes like they were on fire and base of foot were inflamed.
Patient should have received Pfizer instead of Moderna as her booster.  She received wrong IMZ.  Her mom knows and pediatrician.  Was told to call us if ANY side effects
Rash 12 days after vaccines over entire body. Lasted 4-5 days.
Tinnitus and hearing loss. Tinnitus was immediate  and extreme, pulsatile tinnitus in the first week, subsiding to tinnitus. Hearing loss has presented itself within the last three weeks. I waited several months before filing this report in the hope that it would subside, but it has only become more pronounced.
COVID-19 TEST POSITIVE; This spontaneous report received from a patient concerned a 49 year old male of unspecified ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26. cov2. s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 041A21A expiry: 18-DEC-2021) dose was not reported, 1 total, administered at left arm on 07-APR-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s. (dose number in series 1). The patient received booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855194 expiry: 08-JUL-2022) dose was not reported, 1 total, administered on 03-DEC-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient took Binax now at home test Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) and tested positive (dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 test positive was not reported. This report was non-serious. This case, from the same reporter is linked to 20220331195.
Vaginal spotting 24 hours after vaccination , on 4-9-2021 Headache, arm soreness noted 48 hours after vaccination, lasting ~ 24 hours , noted 4-10-2021 Bruise at site of injection noted on 4-12?may have been present prior to this date but went unnoticed
ADVERSE REACTION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced adverse reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of adverse reaction was not reported. This report was non-serious.
Initial information has been received from a nurse referring to a patient of unknown age and gender. The nurse reported that an unspecified patient was administered a dose of (Oka-Merck) PROQUAD (dose, route and lot number not provided) on 23-FEB-2015, which was improperly stored. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Patient woke with left hemiparesis went to the emergency room  at Hospital.     patient received IV heparin with resolution of hemiparesis.  Medical records show that patient was advised hospitalization is stroke center declined and left against medical advice.   On my evaluation on September 20, 2021 there have been no recurrence of symptoms
Nausia, Weekness, Disiness , total weakness. Note: This was the Moderna Booster. 1st vacine was Jan 15, 2021, 2nd was 2 13, 2021; Booster 9 17, 2020 * This was the Booster Moderna   I was advised to get Moderna because of Allergies.  Booster made me sicker than the original or the 2nd   1st Vaccine was  Jan 16, 2021  2ns was Fwb 13, 2021
Frequent PAC's/APCs after exercise - persistent for hours.  Atrial bigeminy on ECG.  Evaluated in ED - no MI, ECHO normal.  No treatment - f/u with Cardiology.  Note I have a history of AFIB treated medically then with ablation (PVI) in 2009.  NO arrhythmias again until 08Nov2021.  This new arrhythmia persists to this date - triggered by exercise.
I have been sick with a low grade temperature; I am tired; achy; chills; maybe I had the flu; Low grade fever; Nausea; This is a spontaneous report from a contactable consumer (patient). A 61-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 29Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient got her first Pfizer shot on the 29th and was due to go for her second shot tomorrow. She has been sick with a low grade temperature but was feeling much better now. She got a Covid test today but the results won't be back for three days and she fly back home on Friday. She was tired and achy and have the chills. She thought maybe she had the flu. A day and a half ago she started experiencing a little chill, a low grade fever, and nausea. She doesn't know if these symptoms are from the vaccine, she thought she had the flu. Outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pts eyes swelled one eye swelled totally shut. Other eye wasn't as bad. Slight rash at right injection site. Was given Epipen in the ER and is on steroids x 2 days. Pt completely recovered by the next day 8/17/06.
Listless; Sore; Blah; Tired; This spontaneous case was reported by a consumer and describes the occurrence of LISTLESS (Listless), PAIN (Sore), FEELING ABNORMAL (Blah) and FATIGUE (Tired) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031-A2419 and 006-M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FISH OIL and CHONDROITIN SULFATE, GLUCOSAMINE (GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE;GLUCOSAMINE]) for an unknown indication.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LISTLESS (Listless), PAIN (Sore), FEELING ABNORMAL (Blah) and FATIGUE (Tired). On 10-May-2021, LISTLESS (Listless), PAIN (Sore), FEELING ABNORMAL (Blah) and FATIGUE (Tired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were included high blood pressure medication, medication to treat high cholesterol, medication to treat "PSA" levels for prostate The treatment information was unknown.  Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-123330 (E2B Linked Report). This case was linked to MOD-2021-123068 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-123330:Case for husband
first day extreme tired, second day stiff neck that lasted 3 days, day 13 heaviness in chest, day 14 skin rash on site of vaccine
States - she feels disconnected from her body. Had neuro reaction to swine-flu in 1960s this was similar - gradually lessened over next 3 days.
Patient called into the pharmacy on 8/13/21 and stated that she had her second dose of the Moderna COVID vaccination on 4/27/21 at 3:45pm and by 11:30am on 4/28/21 she was having the usual side effects (fatigue, flu-like symptoms including a 101 temperature and a slight headache). On 4/27/21 she had an excruciating headache and she called  her partner who came over and she was taken to the hospital because he stated she had an altered mental status and patient also reported she was very foggy. At the hospital she was discharged with plavix and atorvastatin due to narrowing of a coronary artery and lisinopril due to high blood pressure.
possible injection site granulomas; bump under the skin; This spontaneous report was received from a medical assistant and refers to a 42-year-old female patient. The patient did not have any pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 17-DEC-2019, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 1 dose, lot # R025729, expiration date 18-JUN-2021, intramuscularly (site of administration was not provided). On the same day, the patient developed a bump under the skin and possible injection site granulomas. The outcome of the events was reported as not recovered/not resolved. The relatedness between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was not provided.
Severe lower back pain then severe sciatic nerve pain left side from my butt down the back of my leg. Brutal been of work for 13 weeks.
Narrative: The exact date of reaction is unknow. On the patient's second moderna vaccine he experienced a rash which the patient described as blisters scattering to different parts of his body including thumb, shoulder, bilateral buttocks. This reaction was resolved with Medrol dosepak.
Case number PHHY2014US035991, is an initial literature report received on 21 Mar 2014. In this article, the author mentioned about the events after influenza vaccination for a 03-year-old girl. She had a known history of peanut, tree nut and shellfish allergy. She had pollen-food allergy syndrome from melons and bananas. She avoided gummy candies and other foods containing gelatin because she disliked them. She was vaccinated with influenza vaccine (not specified seasonal or pandemic, manufacturer and batch number: not reported, so conservatively coded as Influenza vaccine INN) on an unknown date. On an unknown date, immediately after vaccination she experienced shortness of breath and tightness of the chest. The outcome and seriousness of the events were not reported. The patient again received influenza vaccine next year and experienced the same events (see case: PHHY2014US037836).
very concerned and anxious about her future prognosis with symptoms lasting now 5 months; left ear pain, fluid, and fullness; left ear pain, fluid, and fullness; left ear pain, fluid, and fullness; very enlarged, firm, and painful lymph nodes; This spontaneous case was reported by an other health care professional and describes the occurrence of LYMPHADENOPATHY (very enlarged, firm, and painful lymph nodes), EAR PAIN (left ear pain, fluid, and fullness), ANXIETY (very concerned and anxious about her future prognosis with symptoms lasting now 5 months), OTORRHOEA (left ear pain, fluid, and fullness) and EAR DISCOMFORT (left ear pain, fluid, and fullness) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced LYMPHADENOPATHY (very enlarged, firm, and painful lymph nodes). On 15-Jun-2021, the patient experienced EAR PAIN (left ear pain, fluid, and fullness), OTORRHOEA (left ear pain, fluid, and fullness) and EAR DISCOMFORT (left ear pain, fluid, and fullness). On an unknown date, the patient experienced ANXIETY (very concerned and anxious about her future prognosis with symptoms lasting now 5 months). At the time of the report, LYMPHADENOPATHY (very enlarged, firm, and painful lymph nodes), EAR PAIN (left ear pain, fluid, and fullness), ANXIETY (very concerned and anxious about her future prognosis with symptoms lasting now 5 months), OTORRHOEA (left ear pain, fluid, and fullness) and EAR DISCOMFORT (left ear pain, fluid, and fullness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Aug-2021, Ultrasound Doppler: abnormal (abnormal) 1 cm node with non-pathological results..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Symptoms: It was reported that on 10-Apr-2021, the patient started experienced a cluster of swollen lymph nodes in supraclavicular fossa on the left side, became enlarged, firm & painful, she had an appointment with ENT for the symptoms as the adenopathy was not completely resolved, pain was resolved but she had non painful nodes in that region. She was prescribed a TMJ regimen. After she was undergone an ultrasound which showed that left ear pain was resolved with minimal fullness, her follow up was schedule for Feb 2022.  No concomitant medications were reported No treatment medications were reported.
Side effects manifested after second dose as a migrane in the early morning (~4:30 AM). Migrane persisted for the next hour before the pain noticable dissappated; completely clear by 8:00 AM. Nasal congestion arose for a brief moment at approximately 6:30 AM but did not persist for longer than ten minutes. If relevant: I attended a gym (crossfit) session at 6:15 PM on 01/08/2021 which lead to deeper breathing, elevated heart rate, and major sweating. No side effects appeared to manifest at this time.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 04-OCT-2010, the patient was inocculated with ZOSTAVAX, (lot# and route unknown), by the clinic (unspecified healthcare professional) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 22-APR-2013, the patient was treated by a physician for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX. The outcome of the events was unknown. Additional information has been requested.
Flu like symptoms; Flushed; Upset stomach; Achyness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), FLUSHING (Flushed), ABDOMINAL DISCOMFORT (Upset stomach), PAIN (Achyness) and FATIGUE (Fatigue) in a 57-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 80777-0102-96) for COVID-19 prophylaxis.    Co-suspect products included non-company products VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) for an unknown indication and INFLUENZA VACCINE INACT SAG 3V (FLUCELVAX) for an unknown indication.    The patient's past medical history included COVID-19 on 27-Jul-2023.   On 31-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use) .5 milliliter and dose of VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) (unknown route) 1 dosage form. On an unknown date, the patient received dose of INFLUENZA VACCINE INACT SAG 3V (FLUCELVAX) (unknown route) 1 dosage form. On 01-Nov-2023, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), FLUSHING (Flushed), ABDOMINAL DISCOMFORT (Upset stomach), PAIN (Achyness) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) (oral use) at a dose of 600 milligram. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), FLUSHING (Flushed) and FATIGUE (Fatigue) was resolving and ABDOMINAL DISCOMFORT (Upset stomach) and PAIN (Achyness) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use), the reporter did not provide any causality assessments.   The patient had no medical history, concomitant disease or risk factor.   The events partially resolved two days after dose but upset stomach and achyness persisted. The patient did not experience any additional symptoms/events. There were no lab data/results available.
Menstrual bleeding since second vaccine till date. Its been more than a month now. Bleeding doesnt stop. And its heavy.
Fever for approximately 12 hours, body chills for approximately 12 hours, headache for approximately 24 hours, queasy stomach for approximately 24 hours. After taking the second Moderna shot on 2/11/2021 I woke up on 2/12/2021 and started to develop symptoms that included a fever of 100.5, body chills and aches, a headache and upset stomach. These symptoms lasted approximately 10-12 hours before the fever decreased and the body chills went away. On 2/13/2021 I still had a mild headache and queasy stomach. On 2/14/2021 I did not experience any symptoms.
Diarrhea multiple times a day (2-4), fussier than normal, and now projectile spits up after every feeding. We didn?t have this issue at all prior to the second dose. First dose had diarrhea for a few days and subsided.
Chest pain on the left side and my Arms get numbed. This can happen at rest, during sleep or having activities. The pain is sharp and usually lasts 15 to 60 minutes. In March 2022, I had to go to Emergency room since I thought I was having a heart attack. the pain eases If I stand up, but will come back as soon as I lay down or sit.
on my legs I am getting really itchy and like red, I want to say like small red bumps; on my legs I am getting really itchy and like red, I want to say like small red bumps; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: FA7484) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, patient's legs getting really itchy and red like small red bumps. Consumer was informed safety report will be filed and contact the doctor for emergency. The outcome of the events was unknown.  No further information was reported.
This is in follow-up to report(s) previously submitted on 1/5/2007. Information has been received from a physician concerning a 23 year old female who on 01-NOV-2006 was vaccinated, in the left arm, with a first dose of GARDASIL (lot #653938/0954F). On approximately 23-NOV-2006, the patient developed swelling in her lymph node in her axilla (previously reported as swelling in her lymph node area). Unspecified medical attention was sought. On approximately 03-JAN-2007, the patient recovered. Additional information is not available.
The patient felt immediate burning or stinging, then within one minute she had her head slump over in the chair, her hands clenched with mild tremors with loss of consciousness with loss of urine. She was out for about 45 seconds. She had immediate orientation upon awakening but remained hypotensive with a low heart rate for about 10 minutes after. She recovered well with laying flat. Her blood pressure went to 78/56 with a heart rate of 45 (normal bp 110/80 and HR of 70) She received the influenza vaccine at the same time (not her first) and the Moderna vaccine was administered about 30 seconds after the HPV  and flu vaccine.  (not in the same arm as the HPV)
pt presents to the ED after receiving the J&j vaccine yesterday, pt endorses HA, chills, and nausea, pt has self treated with tylenol and ibuprofen which did not help symptoms.
Narrative:  Received Pfizer MRNA vaccine 1/12/21 and on 1/16/21 patient fell x2 at restaurant and again in his kitchen and was hospitalized after falls. Son reports symptoms of weakness after patient received initial COVID vaccination.
Rash developed around and below injection site. Swelling and red bumps that lasted approximately 10 days.
Headache; Fever; Bodyaches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MYALGIA (Bodyaches) and HEADACHE (Headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), MYALGIA (Bodyaches) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever) and MYALGIA (Bodyaches) had resolved and HEADACHE (Headache) had not resolved.            No Concomitant medications were reported. No treatment medications were reported. Action taken with mRNA-1273 in response to the events were Not Applicable.